Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b2cc52f53195aff63c7a27649a79fc5 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
filingDate |
2005-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a70d72ab2582e400b53a8f30a94eb2ae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_935bf809f2af8117b59ebbb03abee887 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71b5072c70f1c6d57d6bd747f1e613c0 |
publicationDate |
2005-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20050111532-A |
titleOfInvention |
Delivery agents for enhancing mucosal absorption of biologically active agents |
abstract |
The delivery agents developed for enhancing mucosal absorption of biologically active agents in warm-blooded animals are amphiphiles chemically covalently bonded to hydrophilic and hydrophobic sites. The hydrophobic moiety may comprise molecules of bile acids, sterols or hydrophobic termini. The hydrophilic moiety may comprise a molecule of α-amino acid, dipeptide or tripeptide or hydrophilic terminus. Specific examples of the delivery agent include N α -deoxycholyl-L-lysine-methylester. The delivery agent for enhancing mucosal absorption is administered to warm-blooded animals after forming a physical complex with a biologically active agent. The above delivery / biologically active agent complexes are particularly useful for oral administration, but administration by other routes is also possible. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220115413-A |
priorityDate |
2004-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |